Clinical Trial Update: S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis [Phase 2]

View source ↗

Summary

Phase 2 SWOG trial evaluating dexamethasone plus interferon alfa in AL amyloidosis has completed enrollment. The update does not provide detailed efficacy or sa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis
• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Interferon Alfa (interferon alfa)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED